Dynamic Technology Lab’s Genmab GMAB Stock Holding History

Dynamic Technology Lab’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,120	Closed	-$309K	–	1093
2023 Q2	$309K	Buy	+8,120	New	+$324K	0.04%	695

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dynamic Technology Lab's GMAB Position: Q3 2023 in Review

Dynamic Technology Lab sold out of Genmab (GMAB) in Q3 2023, closing a stake of 8,120 shares — an estimated $309K sold.

Dynamic Technology Lab first reported a position in GMAB in Q2 2023 and held it in 1 quarter. The position peaked at $309K in Q2 2023. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

Dynamic Technology Lab reported no remaining Genmab position as of Q3 2023 after selling out during the quarter.
Dynamic Technology Lab sold 8,120 Genmab shares in Q3 2023, an estimated $309K.
Dynamic Technology Lab first reported a position in Genmab in Q2 2023 and held it in 1 quarter.
Dynamic Technology Lab's Genmab position peaked at $309K in Q2 2023.
233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Dynamic Technology Lab's 13F filing for Q3 2023, filed 14 Nov 2023.